The use of such drugs to block the effects of epinephrine will provide a more specific test in the diagnosis of pheochromocytoma. However, such agents as the benzodioxane derivatives can produce ...

Comprehensive reviews of the literature related to management and diagnosis of pheochromocytoma are available elsewhere.

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

Rahway, New Jersey Tuesday, January 28, 2025, 10:00 Hrs [IST] ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

During his time in Columbus, Dr. Miller published an illustrated book, “Principles of Health Preservation”, which observed ...

focused on the evaluation of postoperative management of patients with pheochromocytoma assessing hemodynamic ... that since PPGL recurrence can occur at any time after the initial diagnosis of PPGL, ...

Results from the trial will be presented at an upcoming medical meeting. “Pheochromocytoma and paraganglioma are rare tumors that form in and around the adrenal glands, and currently, there are no ...